Article
The hallmarks of premalignant conditions: a molecular basis for cancer prevention.
Seminars in oncology - 1 Feb 2016
Ryan Bríd M, Faupel-Badger Jessica M
Abstract excerpt
The hallmarks of premalignant lesions were first described in the 1970s, a time when relatively little was known about the molecular underpinnings of cancer. Yet it was clear there must be opportunities to intervene early in carcinogenesis. A vast array of molecular information has since been uncovered, with much of this stemming from studies of existing cancer or cancer models. Here, examples of how an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
